Effects of FDA Authorized Smokeless Tobacco Claims Among US Adults Who Smoke Cigarettes
Completed · Not applicable
Conditions studied: Tobacco Product Beliefs and Use
In brief
This study will be an online survey experiment conducted with adults who smoke cigarettes (ages 21+) to examine their reactions to modified risk advertising claims authorized by the Food \& Drug Administration (FDA) for two smokeless tobacco brands (General Snus and Copenhagen), which describe the lower risks of these products compared to cigarette smoking. The study will compare effects of ads with different two different claim types (i.e. claims about reduced lung cancer risk and claims about reduced risks for multiple disease) versus ads with no reduced-risk claims, and examine effects on message and product perceptions, and interest in using the smokeless tobacco products. This study will also examine how smokers' reactions/interest may vary based on the product brand, and asses prior awareness/exposure to the authorized claims.
Key facts
- Study ID
- NCT06927700
- Run by
- Rutgers, The State University of New Jersey
- People needed
- 1257
- Starts
- 2025-04-24
- Expected to finish
- 2025-05-04
- Last updated by the study team
- 2026-03-04
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Adults (age 21 and over) who are current established cigarettes smokers (i.e., smoked 100 cigarettes in their lifetime and now smoke every day or somedays), based in the US, members of Ipsos' KnowledgePanel, and have chosen to complete their research panel surveys in English
You may not qualify if…
- Panel participants who do not meet the criteria outlined above will be excluded.
Where it is running
- Rutgers Institute for Nicotine & Tobacco Studies — New Brunswick, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.